pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
orziloben
Liver Diseases
NorthSea Therapeutics BV
0
catalysts
Phase 2
osemitamab
Gastroesophageal (GE) Junction Carcinomas
Transcenta Holding Ltd
0
catalysts
Phase 2
oxymetazoline
oxymetazoline [INN]
Ptosis
Levation Pharma Ltd
0
catalysts
Phase 2
ozureprubart
Food Allergy
← prev
page 43 of 50
next →
131
Pain
89
Neurology
1
RAPT Therapeutics Inc
0
catalysts
Phase 2
ozuriftamab vedotin
Head And Neck Cancer
$BCAB
BioAtla, Inc.
0
catalysts
Phase 2
pacibekitug
Atherosclerosis
Interleukin-6
Tourmaline Bio Inc
0
catalysts
Phase 2
palacaparib
palacaparib [INN]
Malignant Glioma
$AZN
ASTRAZENECA PLC
0
catalysts
Phase 2
pamlectabart tismanitin
pamlectabart tismanitin [INN]
Refractory Multiple Myeloma
Heidelberg Pharma AG
0
catalysts
Phase 2
panobacumab
Aerumab (panobacumab [INN])
Hospital Acquired Pneumonia (HAP)
Aridis Pharmaceuticals Inc
0
catalysts
Phase 2
peceleganan
peceleganan [INN]
Diabetic Foot Ulcers
Jiangsu ProteLight Pharmaceutical And Biotechnology Co Ltd
0
catalysts
Phase 2
pegevongitide
pegevongitide [INN]
Coronavirus Disease 2019 (COVID-19) Pneumonia
Vasomune Therapeutics Inc
0
catalysts
Phase 2
pegsebrenatide
pegsebrenatide [INN]
Multiple Sclerosis
Neuraly Inc
0
catalysts
Phase 2
pegtarazimod hydrochloride
Chronic Obstructive Pulmonary Disease (COPD)
ReAlta Life Sciences Inc
0
catalysts
Phase 2
pelareorep
Reolysin (pelareorep)
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$ONCY
ONCOLYTICS BIOTECH INC
0
catalysts
Phase 2
pelcitoclax
pelcitoclax [INN]
Neuroendocrine Tumors
$AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
0
catalysts
Phase 2
peltopepimut-s
Cervical Cancer
ISA Pharmaceuticals BV
0
catalysts
Phase 2
peluntamig
Neuroendocrine Carcinoma
Phanes Therapeutics Inc
0
catalysts
Phase 2
pemafibrate + tofogliflozin
pemafibrate [INN] + tofogliflozin
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Kowa Co Ltd
0
catalysts
Phase 2
pemvidutide
Alcohol Use Disorder (AUD)
$ALT
Altimmune, Inc.
0
catalysts
Phase 2
petrelintide
Obesity
Zealand Pharma AS
0
catalysts
Phase 2
pevifoscorvir sodium
Hepatitis B
$ALGS
Aligos Therapeutics, Inc.
0
catalysts
Phase 2
pexastimogene devacirepvec
Metastatic Renal Cell Carcinoma
Granulocyte-macrophage colony-stimulating factor
Sillajen Biotherapeutics
0
catalysts
Phase 2
phenylbutyrate
Chemotherapy Induced Oral Mucositis
Sunny Pharmtech Inc
0
catalysts
Phase 2
pifusertib
pifusertib [INN]
Solid Tumor
Taiho Pharmaceutical Co Ltd
0
catalysts
Phase 2
pilavapadin phosphate
Diabetic Neuropathic Pain
$LXRX
LEXICON PHARMACEUTICALS, INC.
0
catalysts
Phase 2
pirmitegravir
pirmitegravir [INN]
Human Immunodeficiency Virus (HIV) Infections (AIDS)
ST Pharm Co Ltd
0
catalysts
Phase 2
plencifgene parvec
Cystic Fibrosis
$FDMT
4D Molecular Therapeutics, Inc.
0
catalysts
Phase 2
plixorafenib
Central Nervous System (CNS) Tumor
Serine/threonine-protein kinase B-raf
Fore Biotherapeutics Inc
0
catalysts
Phase 2
plogosertib
plogosertib [INN]
Bladder Cancer
Tethra Biosciences Inc
0
catalysts
Phase 2
pocenbrodib hydrochloride
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Pathos AI Inc
0
catalysts
